Rss Feed
Scientists produce a genetic analysis of Lyme disease bacteria
A team led by CUNY Graduate Center biologists has produced a genetic analysis of Lyme disease bacteria that may pave the way for improved diagnosis, treatment, and prevention of the tick-borne ailment.
Ribonucleic acid for injection II enhances immunity and hematopoiesis in immunosuppressed mice
Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by enhancing immune function and suppressing tumor growth.
Study finds IFI27 and IFI6 as potential biomarkers for immune reconstitution in HIV patients
Announcing a new article publication for Zoonoses journal. No novel biomarkers are currently available for evaluating immune reconstitution among people living with HIV/AIDS (PLWH) receiving combined antiretroviral treatment (cART).
Study uncovers rare genetic variants associated with Parkinson's disease
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson's Disease.
Vaping linked to higher risk of cigarette smoking and drug use in teens, young adults
U.S. teens and young adults who vape are much more likely to start smoking cigarettes or to begin using cannabis or other drugs, a new University of Michigan study found.
Scientists discover brain's 'future map'
Researchers from the RIKEN Center for Brain Science (CBS) in Japan have discovered a region of the brain that encodes where an animal is planning to be in the near future. Linked to internal maps of spatial locations and past movements, activity in the newly discovered grid cells accurately predicts future locations as an animal travels around its environment. Published in Science on August 15th, 2024, the study helps explain how planned spatial navigation is possible.
Exploring the mechanics of cell migration and growth
The National Institute of General Medical Sciences, a branch of the National Institutes of Health (NIH), has awarded Yubing Sun, associate professor of mechanical and industrial engineering at the University of Massachusetts Amherst, a $1.9 million Maximizing Investigators' Research Award to support the exploration of the fundamental principles behind the process that close gaps caused by injury or growth between cells. This research has the potential to push forward advances in our understanding of wound healing, cellular regeneration therapies and embryonic development.
Study highlights benefits of exercise for both men and women
Females' and males' muscles differ in glucose and fatty acid handling – but regular physical activity quickly triggers similar beneficial metabolic changes in the muscles of both sexes, new research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Madrid, 9-13 September) has found.
Scientists find way to restore brain's self-cleaning function
Alzheimer's, Parkinson's, and other neurological disorders can be seen as "dirty brain" diseases, where the brain struggles to clear out harmful waste. Aging is a key risk factor because, as we grow older, our brain's ability to remove toxic buildup slows down. However, new research in mice demonstrates that it's possible to reverse age-related effects and restore the brain's waste-clearing process.
Scientists discover key age-related biological shifts at 40 and 60
Researchers uncover the nonlinear dynamics of aging, revealing significant biological shifts at ages 40 and 60, offering new insights into age-related diseases.
Saliva test offers hope for head and neck cancer patients
But what if a mouthwash-based test to detect biomarkers can help physicians predict disease recurrence in head and neck cancer patients?
New target identified to combat menopause-induced obesity
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new study identifies potential therapies that might one day reverse these unhealthy shifts.
Researchers urge inclusion of marginalized groups to bridge bulimia nervosa treatment gaps
Researchers identified significant disparities in bulimia nervosa treatment, urging more inclusive research to address gaps in care for marginalized populations.
Mapping Lyme bacteria for better patient care
A genetic analysis of Lyme disease bacteria may pave the way for improved diagnosis, treatment and prevention of the tick-borne ailment.
Chronic caffeine consumption linked to elevated heart rate and blood pressure
From coffee to tea, caffeinated beverages are an integral part of morning routines across the globe, but these popular drinks can be harmful when enjoyed in excess.
Gut microbiota plays a crucial role in type 2 diabetes management
Research reveals the intricate role of gut microbiota in type 2 diabetes, highlighting personalized therapeutic strategies and the complexity of microbial interactions with antidiabetic drugs.
Study links chronic noise exposure in power loom weavers to increased blood pressure
Noise exposure is a known occupational hazard in some jobs, particularly for hearing loss, physical and psychological stress, and reduced concentration.
Weill Cornell Medicine secures $12.4 million grant for lymphoma research
Weill Cornell Medicine has received a five-year, $12.4 million grant from the National Cancer Institute, part of the National Institutes of Health, for an extensive program of basic and translational research on the biology of diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma.
Federal grant supports research on homelessness among women veterans in Canada
A first-of-its-kind study led by Lawson Health Research Institute is receiving $1.2 million in funding from the federal government, delivered through the Veteran Homelessness Program, to better understand homelessness amongst women in Canada who are military Veterans.
Neoadjuvant immunotherapy yields comparable outcomes in high-risk liver cancer surgery
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery-;including those who would not have been eligible for surgery by conventional criteria-;had similar outcomes to patients who received surgery upfront, according to results from a retrospective study.